The intricacies of pluripotency
Pluripotent stem cells derived from the inner cell mass of a blastocyst or obtained by reprogramming somatic cells using ‘Yamanaka factors’ are termed human embryonic stem (hES) and induced pluripotent stem (iPS) cells respectively. These stem cells have been reported to have maximum potential for...
Main Author: | Bhartiya D |
---|---|
Format: | Article |
Language: | English |
Published: |
GN Corporation Limited
2014-11-01
|
Series: | Journal of Stem Cells and Regenerative Medicine |
Subjects: | |
Online Access: | http://www.pubstemcell.com/monthly/010020700009.htm |
Similar Items
-
Human Monoclonal antibodies - A dual advantaged weapon to tackle cancer and viruses
by: Kurosawa G
Published: (2014-11-01) -
Islet neogenesis potential of human adult stem cells and its applications in cell replacement therapy for diabetes
by: Bhonde RR
Published: (2008-11-01) -
Nanobiotechnology : What? Why? How?
by: Jagannadh B
Published: (2008-11-01) -
Clinical application of mesenchymal stem cells for aseptic bone necrosis
by: Tomoki Aoyama
Published: (2008-11-01) -
Cancer Stem Cells – Basics, Progress and Future Potential
by: Bapat S.A
Published: (2010-01-01)